M. Soresi et al., CIRCULATING, INTERCELLULAR-ADHESION MOLECULE-1 IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA, European journal of gastroenterology & hepatology, 9(8), 1997, pp. 805-809
Background: Intercellular adhesion molecule-1 (ICAM-1) is thought to p
lay an important role in cellular immunological reactions. Expression
can be induced by inflammatory cytokines in a wide variety of cells, i
ncluding hepatocytes. Objective: To compare the behaviour of ICAM-1 in
liver diseases. Patients and methods: We assayed serum ICAM-1 (sICAM-
1) in patients with hepatocellular carcinoma-associated liver cirrhosi
s, and compared them with a group of cirrhotic patients and controls.
sICAM-1 values were also correlated with some biochemical parameters o
f liver function. Moreover, immunohistochemical localization of ICAM-1
was performed on liver tissue sections of patients with hepatocellula
r carcinoma, liver cirrhosis and a sample of normal liver. Results: sI
CAM-1 levels were significantly higher in the hepatocellular carcinoma
patients than in controls (P<0.0001) and the cirrhosis group (P<0.001
). sICAM-1 values directly correlated with alanine aminotransferase, t
otal bilirubin, alkaline phosphatase and gamma-glutamyltranspeptidase
serum values (P<0.05), with an inverse correlation with albuminaemia v
alues (P<0.05). There was no correlation with alpha-fetoprotein values
, but sICAM-1 values were higher in hepatocellular carcinoma patients
with large tumours (>3 cm) than in those with small tumours (<3 cm) (P
<0.04). Immunohistochemical localization of ICAM-1 was negative in nor
mal liver tissue; positive staining for endothelial cells was found in
chronic liver disease, while in hepatocellular carcinoma tissues, pos
itive membrane staining was observed in hepatocytes and, to a lesser e
xtent, at the cytoplasmic level. Conclusion: These results suggest tha
t high serum levels of sICAM-1 are associated with severe liver diseas
e, such as liver cirrhosis and hepatocellular carcinoma, and that they
tend to increase with deteriorating hepatic function and tumour size.